Johnson & Johnson said it is buying Crucell N.V. for $2.41 billion in a move that will boost the American health care company’s vaccine business.
*For more on this story, read the full Associated Press article.
Johnson & Johnson said it is buying Crucell N.V. for $2.41 billion in a move that will boost the American health care company’s vaccine business.
*For more on this story, read the full Associated Press article.
Sign-up for our FREE Daily eNews update to get the latest Orange County news delivered right to your inbox!
One-Year for Only $99